TransCode Therapeutics, Inc.
RNAZ • NASDAQ
TransCode Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Philippe Calais, with a market cap of $8.1M.
Market Cap$8.1M
Employees10.0
CEOPhilippe Calais
CountryUnited States of America
Healthcare
Biotechnology
Financials
TransCode Therapeutics, Inc. FAQ
Common questions about TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. has approximately 10 employees.